Veillon-Berteloot Chantal's Form 4 filing
Integra Lifesciences Holdings Corp (IART) · filed Sep 4, 2026
- Accession no.
- 0001990905-26-000004
- Filed
- Sep 4, 2026, 7:56 AM ET
- Trade date
- Sep 1, 2026
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Veillon-Berteloot ChantalCIK 0001990905 | Officer (EVP & CHRO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | FTax withholdingDisposed | −1,455 | $16.62 | −$24,182.1 | 20,772 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.